Show: 10 · 20 · 50

1. 1

• Caleb Alexander Lab

  Research in the Caleb Alexander Lab examines prescription drug use. This includes studies of population-based patterns and determinants of pharmaceutical use, clinical decision-making about prescription drugs, and the effect of changes in regulatory and payment policies on pharmaceutical utilization. We have special expertise in conducting survey-based studies and analyzing secondary data sources, including administrative claims, the Medical Expenditure Panel Survey and the National Ambulatory Medical Care Survey.

  Research Areas: epidemiology, medical decision making, drug safety, patient-provider relationships, pharmacoepidemiology, drugs

  Lab Website

  

  Principal Investigator

  G Alexander, M.D.

  Department

  Medicine
  

• Grant (Xuguang) Tao Lab

  Research in the Grant (Xuguang) Tao Lab explores environmental and occupational epidemiology topics, including workers' compensation and injuries, and nosocomial infections. We conduct research through clinical trials and systematic literature reviews, and also use cancer registry data and GIS applications in environmental epidemiological research. Our recent studies have explored topics such as the effectiveness of lumbar epidural steroid injections following lumbar surgery, the effect of physician-dispensed medication on workers' compensation claim outcomes and how the use of opioid and psychotropic medications for workers' compensation claims impacts lost work time.

  Research Areas: epidemiology, drug safety, cancer, nosocomial infections, GIS applications

  

  Principal Investigator

  Grant Tao, M.D., M.S., Ph.D.

  Department

  Medicine
  

• Morgan Grams Lab

  Dr. Morgan Grams and her colleagues are involved in a wide range of clinical research projects applying quantitative methods to multidimensional data to develop actionable clinical indicators. Along with Dr. Josef Coresh, Dr. Grams leads the Chronic Kidney Disease (CKD) Prognosis Consortium, a global consortium of over 200 investigators and >11 million participants (https://ckdpc.org). They have developed and validated several risk calculators that are now widely used in clinical practice (https://ckdpcrisk.org). She holds a joint appointment in the Bloomberg School of Public Health, where she is a member of the Center of Drug Safety and Effectiveness. Her research in pharmacoepidemiology leverages electronic health records from multiple countries to evaluate the risks and benefits of commonly used medications across the spectrum of kidney function. Together with her team, Dr. Grams also focuses on identifying targetab...le pathways or biomarkers that underlie the development of chronic kidney disease using multi-omic approaches.
  
  
  
  Dr. Grams received the 2019 Frederick Brancati Mentoring Award. Currently, four of her mentees are supported by NIH K awards. More of their research can be found here: http://www.ncbi.nlm.nih.gov/myncbi/browse/collection/40940579/?sort=date&direction=descending view more

  Research Areas: organ donors, hyperglycemia, biomarkers, chronic kidney disease, health disparities

  Lab Website

  

  Principal Investigator

  Morgan Grams, M.D., M.H.S., Ph.D.

  Department

  Medicine
  

1. 1